Search

Your search keyword '"Masahiro Asai"' showing total 105 results

Search Constraints

Start Over You searched for: Author "Masahiro Asai" Remove constraint Author: "Masahiro Asai"
105 results on '"Masahiro Asai"'

Search Results

1. Impact of microscopic orbital periosteum invasion in orbital preservation surgery

2. Significance of delayed primary excision in localized nonmetastatic adult head and neck rhabdomyosarcoma

4. Synthesis and characterization of dinuclear late transition-metal (copper(I), silver(I), rhenium(I)) complexes with a bis-pyridylimine ligand linked by S–S bonding

5. Analysis of Pharmacist Communication with Patients in Triaging OTC Drugs

6. Surgical management of carcinoma of the cervical esophagus

7. [Alcohol withdrawal syndrome showing various progress: A case report]

10. Taijin Kyofusho in a Japanese Community Population

11. Biochemical and Psychiatric Approach for 'Kyou-kyou-kuman'

12. Serum interleukin-18 levels are elevated in schizophrenia

13. Somatoform Symptoms in a Japanese Community Population: Prevalence and Association with Personality Characteristics

14. Environmental and Possible Genetic Contributions to Character Dimensions of Personality

15. Is Paranoid Schizophrenia the Most Common Subtype?

17. Somatoform Disorders : A Worldwide Perspective

18. Aberrant interleukin-2 receptor-mediated blastoformation of peripheral blood lymphocytes in a severe major depressive episode

19. Neuropsychological assessment of remote memory

20. ‘Alice in Wonderland’ Syndrome as a Precursor of Depressive Disorder

21. Transcultural Study of Schizophrenic Delusions

22. Impact of sociodemographic and diabetes-related characteristics on depressive state among non-insulin-dependent diabetic patients

23. Somatoform Disorders among Patients Who Visit Kampo Clinic

24. The Clinical Effectiveness of Oren-gedoku-to in the Treatment of Schizophrenia

25. Endothelium-dependent and-independent vasoactive actions of a japanese kampo medicine, saiko-ka-ryukotsu-borei-to

26. Search for a Susceptibility Locus to Tardive Dyskinesia

27. Clinical Effectiveness of Oren-Gedoku-To for Insomnia associated with Acute Schizophrenia and Other Psychotic Disorders

28. Relationship of Childhood Abuse to Psychiatric Distress, Social Adjustment, and Eating Disorder Severity in Japanese Bulimics

29. Avoidant personality disorder and taijin kyoufu: Sociocultural implications of the WHO/ADAMHA International Study of Personality Disorders in Japan

30. Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement

31. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat

32. Role of interleukin-1 in stress responses

33. Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients

34. Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients

35. Inhibition by Lithium of Cyclic GMP Formation without Inhibition of Nitric Oxide Generation in the Mouse Neuroblastoma Cell (N1E-115)

36. Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus

37. Radiotherapy for squamous cell carcinoma of the head and neck: Long-term results in patients under 50 years of age

38. Diagnostic and therapeutic issues of atypical depression in Japan

39. In situ SEM Observation of Grain Formation and Growth Induced by Electrical Pulses in Lateral Ge2Sb2Te5 Phase-change Memory

40. Characteristics of N-doped Sb2Te3 Films by X-ray Diffraction and Resistance Measurement for Phase-change Memory

41. TCI temperamental scores in bulimia nervosa patients and normal women with and without diet experiences

42. Possibility to read out 20-nm-sized pits using a near-field optical probe in an atomic force cantilevered snom

43. Monoamine oxidase genes polymorphisms and mood disorder

44. BRIEF COMMUNICATION

45. Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia

47. Nilvadipine Is Effective for Chronic Schizophrenia in a Double-Blind Placebo-Controlled Study

48. Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode

49. Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients

50. Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study

Catalog

Books, media, physical & digital resources